141 related articles for article (PubMed ID: 6712963)
1. Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.
Poulos A; Ranieri E; Shankaran P; Callahan JW
Biochim Biophys Acta; 1984 Apr; 793(2):141-8. PubMed ID: 6712963
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease.
Poulos A; Shankaran P; Jones CS; Callahan JW
Biochim Biophys Acta; 1983 May; 751(3):428-31. PubMed ID: 6303435
[TBL] [Abstract][Full Text] [Related]
3. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
Christomanou H
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
[TBL] [Abstract][Full Text] [Related]
4. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
Poulos A; Ranieri E; Shankaran P; Callahan JW
Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
[TBL] [Abstract][Full Text] [Related]
5. Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen.
Christomanou H; Kleinschmidt T
Biol Chem Hoppe Seyler; 1985 Mar; 366(3):245-56. PubMed ID: 4005041
[TBL] [Abstract][Full Text] [Related]
6. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
Klar R; Levade T; Gatt S
Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
[TBL] [Abstract][Full Text] [Related]
8. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
Graber D; Salvayre R; Levade T
J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
[TBL] [Abstract][Full Text] [Related]
9. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.
Gal AE; Brady RO; Hibbert SR; Pentchev PG
N Engl J Med; 1975 Sep; 293(13):632-6. PubMed ID: 239343
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of sphingomyelin in cultured skin fibroblasts from patients with different types of Niemann-Pick disease.
Nakashima M; Kudoh T; Sukegawa K; Maruyama K; Orii T
Tohoku J Exp Med; 1986 Apr; 148(4):365-71. PubMed ID: 3738903
[TBL] [Abstract][Full Text] [Related]
11. Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates.
Besley GT; Moss SE
Biochim Biophys Acta; 1983 Jun; 752(1):54-64. PubMed ID: 6303436
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
Sutrina SL; Chen WW
Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
[TBL] [Abstract][Full Text] [Related]
13. Effects of dimethylsulfoxide on sphingomyelinase activities in normal and Niemann-Pick type A, B and C fibroblasts.
Sato M; Yoshida Y; Sakuragawa N; Arima M
Biochim Biophys Acta; 1988 Sep; 962(1):59-65. PubMed ID: 2843241
[TBL] [Abstract][Full Text] [Related]
14. Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms.
Besley GT; Elleder M
J Inherit Metab Dis; 1986; 9(1):59-71. PubMed ID: 3014212
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelinase in cultured skin fibroblasts from normal and Niemann-Pick type C patients.
Poulos A; Hudson N; Ranieri E
Clin Genet; 1983 Oct; 24(4):225-33. PubMed ID: 6315279
[TBL] [Abstract][Full Text] [Related]
16. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.
Andrieu N; Salvayre R; Levade T
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):341-5. PubMed ID: 7980390
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.
Christomanou H; Aignesberger A; Linke RP
Biol Chem Hoppe Seyler; 1986 Sep; 367(9):879-90. PubMed ID: 3024666
[TBL] [Abstract][Full Text] [Related]
18. Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease.
Schneider PB; Kennedy EP
J Lipid Res; 1967 May; 8(3):202-9. PubMed ID: 4962590
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Niemann-Pick disease using a simple and sensitive fluorimetric assay of sphingomyelinase activity.
Besley GT
Clin Chim Acta; 1978 Dec; 90(3):269-78. PubMed ID: 31994
[TBL] [Abstract][Full Text] [Related]
20. Studies on sphingomyelinase activity in cultured cells and leucocytes.
Besley GT
J Inherit Metab Dis; 1978; 1(1):29-33. PubMed ID: 229341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
